Margaret G. McGlynn, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 12,500 shares at $126.78 ($1.6M) on 2015-06-01, disclosed to the SEC on 2015-06-03.
Scheduled sale ($1.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $126.78 | 3,480 | $441K | 27.7% |
| 2 | $127.53 | 9,020 | $1.2M | 72.3% |
| Total | $127.32 avg | 12,500 | $1.6M | 100% |
| Filing → |
| FOLD | SELL | 2022-05-04 | $105K | — | Filing → |
| VRTX | SELL | 2022-04-12 | $1.4M | — | Filing → |
| VRTX | SELL | 2022-04-04 | $2.6M | — | Filing → |